Open Access

Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model

  • Authors:
    • Shibin Song
    • Yimin Chen
    • Feng Han
    • Minghao Dong
    • Xin Xiang
    • Jianmei Sui
    • Yuming Li
    • Hua Yang
    • Jian Liu
  • View Affiliations

  • Published online on: February 26, 2018     https://doi.org/10.3892/etm.2018.5896
  • Pages: 3847-3855
  • Copyright: © Song et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Aloperine (ALO) exhibits neuroprotective effects against oxidative stress in vitro; however, its protective effect in early brain injury (EBI) following experimental subarachnoid hemorrhage (SAH) remains to be elucidated. The aim of the current study was to evaluate the antioxidant activity of ALO in EBI, and its association with nuclear factor erythroid‑related factor 2 and the antioxidant responsive element (Nrf2‑ARE) survival pathway. In the present study, an experimental SAH model was induced in rats following a prechiasmatic cistern injection. All rats were randomly divided into five groups: Sham, SAH, SAH+ vehicle, and an SAH+ ALO group (including low and high doses). ALO was administrated intraperitoneally at 2 and 24 h following induction of the SAH model. Brain samples were collected from each group at 48 h after SAH induction. Subsequently, western blotting, immunohistochemistry and cell apoptosis assays were performed, along with assessments for brain edema, neurological deficit, and the activity of oxidant/antioxidant factors. It was observed that the expression of Nrf2‑ARE pathway‑associated agents, including Nrf2, and heme oxygenase‑1, were markedly increased in the high concentration ALO group compared with that of the SAH group. In addition, the level of oxidative damage was reduced. Furthermore, early brain damage, including brain edema, neurological deficit and cellular apoptosis were significantly ameliorated. In conclusion, the results of the present study indicate that ALO can ameliorate oxidative damage against EBI following SAH, most likely via the Nrf2‑ARE survival pathway.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Song S, Chen Y, Han F, Dong M, Xiang X, Sui J, Li Y, Yang H and Liu J: Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model. Exp Ther Med 15: 3847-3855, 2018
APA
Song, S., Chen, Y., Han, F., Dong, M., Xiang, X., Sui, J. ... Liu, J. (2018). Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model. Experimental and Therapeutic Medicine, 15, 3847-3855. https://doi.org/10.3892/etm.2018.5896
MLA
Song, S., Chen, Y., Han, F., Dong, M., Xiang, X., Sui, J., Li, Y., Yang, H., Liu, J."Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model". Experimental and Therapeutic Medicine 15.4 (2018): 3847-3855.
Chicago
Song, S., Chen, Y., Han, F., Dong, M., Xiang, X., Sui, J., Li, Y., Yang, H., Liu, J."Aloperine activates the Nrf2‑ARE pathway when ameliorating early brain injury in a subarachnoid hemorrhage model". Experimental and Therapeutic Medicine 15, no. 4 (2018): 3847-3855. https://doi.org/10.3892/etm.2018.5896